3 Reasons to Sell TFX and 1 Stock to Buy Instead

Over the last six months, Teleflex’s shares have sunk to $111.34, producing a disappointing 12.2% loss - a stark contrast to the S&P 500’s 16.4% gain. This may have investors wondering how to approach the situation.

Is now the time to buy Teleflex, or should you be careful about including it in your portfolio? Get the full stock story straight from our expert analysts, it’s free for active Edge members.

Why Is Teleflex Not Exciting?

Even though the stock has become cheaper, we're sitting this one out for now. Here are three reasons we avoid TFX and a stock we'd rather own.

1. Weak Constant Currency Growth Points to Soft Demand

Investors interested in Surgical Equipment & Consumables - Specialty companies should track constant currency revenue in addition to reported revenue. This metric excludes currency movements, which are outside of Teleflex’s control and are not indicative of underlying demand.

Over the last two years, Teleflex’s constant currency revenue averaged 3% year-on-year growth. This performance slightly lagged the sector and suggests it might have to lower prices or invest in product improvements to accelerate growth, factors that can hinder near-term profitability.

2. Free Cash Flow Margin Dropping

Free cash flow isn't a prominently featured metric in company financials and earnings releases, but we think it's telling because it accounts for all operating and capital expenses, making it tough to manipulate. Cash is king.

As you can see below, Teleflex’s margin dropped by 12.1 percentage points over the last five years. If its declines continue, it could signal increasing investment needs and capital intensity. Teleflex’s free cash flow margin for the trailing 12 months was 8.4%.

3. New Investments Fail to Bear Fruit as ROIC Declines

ROIC, or return on invested capital, is a metric showing how much operating profit a company generates relative to the money it has raised (debt and equity).

We like to invest in businesses with high returns, but the trend in a company’s ROIC is what often surprises the market and moves the stock price. Unfortunately, Teleflex’s ROIC has decreased over the last few years. Paired with its already low returns, these declines suggest its profitable growth opportunities are few and far between.

Final Judgment

Teleflex isn’t a terrible business, but it doesn’t pass our bar. After the recent drawdown, the stock trades at 7.6× forward P/E (or $111.34 per share). While this valuation is optically cheap, the potential downside is big given its shaky fundamentals. We're pretty confident there are superior stocks to buy right now. We’d recommend looking at a top digital advertising platform riding the creator economy.

Stocks We Like More Than Teleflex

If your portfolio success hinges on just 4 stocks, your wealth is built on fragile ground. You have a small window to secure high-quality assets before the market widens and these prices disappear.

Don’t wait for the next volatility shock. Check out our Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.

StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.